Back to DYN

Vestal Point Capital, LP → DYN

Vestal Point Capital, LP DYN Position History

Dyne Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$99.9M
Q3 2026
Peak value
$99.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$2.3M
Q1 2026$72.5M
Q2 2026$75M
Q3 2026$99.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$99.9M6.20M——
Q2 2026$75M3.38M——
Q1 2026$72.5M4.00M——
Q4 2025$2.3M120.0K——

Other funds holding DYN

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M